How to Buy Beigene Stock
Beigene Ltd
BeiGene, Ltd. , a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide.
Beigene stock last closed at $175.00, down 2.43% from the previous day, and has decreased 12.84% in one year. It has overperformed other stocks in the Biotechnology industry by 0.12 percentage points. Beigene stock is currently +11.78% from its 52-week low of $156.56, and -37.64% from its 52-week high of $280.62.
At the moment, there are 1.36B shares of BGNE outstanding. The market capitalization of BGNE is $18.32B. In the past 24 hours, 238,529 BGNE shares were traded.
How to Buy Beigene Stock
Wondering how to invest in Beigene stock? Here's how.
- Choose where to buy Beigene stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Beigene stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Pick your payment method and add your information.
- Evaluate Beigene stock: The Beigene ticker symbol is BGNE. Is Beigene stock a good investment? Should you buy shares of BGNE? How do BGNE's underlying business fundamentals look? Do top analysts think Beigene is a good buy? Why has BGNE's stock price moved recently? (Hint: Our stock analysis website can help you understand if BGNE is a good stock to buy).
- Place your BGNE purchase: Decide if you will purchase BGNE shares at the current market price or use a limit order to buy BGNE stock at a specific price.
- Monitor your BGNE position: Create a watchlist to get the latest news on your new investment in Beigene shares.
Step 1: Choose where to buy Beigene stock
You will need an online brokerage account in order to access the NASDAQ market and buy BGNE shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you are able to invest in BGNE stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open your new trading account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've created your account on the best stock broker app, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help depositing funds into your new brokerage account.
Step 4: Evaluate Beigene stock
After you have figured out the best place to buy Beigene stock, it's very important to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the upside.
Beigene quick stats
Fundamentals of BGNE
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on BGNE's stock page.
Is BGNE stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge BGNE's true value.
Using relative valuations methods:
- BGNE could be undervalued based on its P/B ratio of 4.87x, relative to Biotechnology industry P/B ratio of 5.42x
You can do additional valuation analysis on BGNE's stock here.
BGNE Financial Health
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the BGNE balance sheet.
- BGNE has cash burn of 1789714000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the BGNE balance sheet.
- BGNE has $3.19B in cash and short term investments. This is enough to cover its annual cash burn of $1.79B.
Negative Health Checks:
- Total BGNE debt is higher than 5 years ago, relative to shareholder equity.
- BGNE profit margin has gone up by 1.29 percentage points in the past year, but the company is still unprofitable.
- BGNE has a relatively high debt to equity ratio of 0.47.
Do analysts think it's a good time to buy BGNE stock
Out of 6 Equities analysts who track BGNE, the consensus analyst rating on Beigene is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
Latest BGNE Analyst Forecasts
Xiling Chen, a bottom 38% analyst from JP Morgan maintains BGNE with a strong buy rating and raises their BGNE price target from $297.00 to $300.00, on Aug 7, 2023.
Rebecca Liang, a bottom 32% analyst from Bernstein downgrades BGNE to a hold rating and lowers their BGNE price target from $335.00 to $196.00, on Jun 30, 2023.
You can dive deeper into what analysts are forecasting on the Beigene stock forecast page.
BGNE Technicals
Is BGNE Making Money?
Last year, BGNE revenue was $2.20B. Over the last five year, BGNE's revenue has increased by 69.47% per year. This was faster than the Biotechnology industry average of 37.17%.
Dive into BGNE's earnings and revenue performance here.
Latest Insiders Trades at BGNE
In the last 12 months, insiders at BGNE have sold more shares than they have bought.
Baker Bros Advisors LP, Director of BGNE, was the latest BGNE insider to sell. They sold $182,063,130.00 worth of BGNE shares on Nov 14, 2023.
Research more about who owns BGNE shares here.
Can I rely on BGNE as an income stream?
No, Beigene doesn't provide an income stream by paying out dividends.
What do other traders have to say about BGNE?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your BGNE purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given price limit, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you need more info about buying stocks on eToro, watch the helpful video below:
Step 6: Monitor your BGNE position
Now that you own some shares in BGNE, you'll want to keep up with your investment.
Put BGNE on a watchlist to get the latest updates about your BGNE stock.
BGNE Feed
How to Buy Stock in Beigene
To reiterate, here are the 6 steps to buy stock in Beigene:
- Choose where to buy Beigene stock
- Create your brokerage account
- Put funds into your investment account
- Evaluate Beigene stock
- Place your BGNE purchase
- Monitor your BGNE position
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to monitor your investment in Beigene, add BGNE to your watchlist by clicking the button below.
Other Content You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.